Allogeneic HB-adMSCs

HB-adMSCs · Hope Biosciences LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic HB-adMSCs, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury [Phase 1, Phase 2]